Evolent Health (EVH) Enterprise Value (2015 - 2026)

Evolent Health's Enterprise Value history runs 12 years deep, the most recent figure standing at -$166.0 million for Q1 2026.

• On a quarterly basis, Enterprise Value rose 40.26% year-over-year to -$166.0 million in Q1 2026; TTM through Mar 2026 was -$166.0 million, a 40.26% increase from a year earlier, with the FY2025 full-year figure at -$178.0 million, down 8.86% from the prior year.
• Enterprise Value improved to -$166.0 million in Q1 2026 per EVH's latest filing, from -$178.0 million in the prior quarter.
• Across five years, Enterprise Value topped out at -$127.9 million in Q3 2024 and bottomed at -$280.4 million in Q2 2022.
• The 5-year median for Enterprise Value is -$194.8 million (2022), against an average of -$199.1 million.
• Across the five-year window, Enterprise Value jumped 43.05% in 2024 and fell 27.13% in 2025, its largest moves.
• Year by year, Enterprise Value stood at -$215.2 million in 2022, then climbed by 3.98% to -$206.6 million in 2023, then gained by 20.86% to -$163.5 million in 2024, then dropped by 8.86% to -$178.0 million in 2025, then climbed by 6.75% to -$166.0 million in 2026.
• Per Business Quant, the three latest EVH Enterprise Value figures stand at -$166.0 million (Q1 2026), -$178.0 million (Q4 2025), and -$140.4 million (Q3 2025).